Inherited Thyroid Tumors With Oncocytic Change
Familial non-medullary thyroid carcinoma (FNMTC) corresponds to 5-10% of all follicular cell-derived carcinoma (FCDTC). Oncocytic thyroid tumors have an increased incidence in the familial context in comparison with sporadic FCDTC, encompassing benign and malignant tumors in the same family presenti...
Main Authors: | Marcelo Correia, Ana Rita Lima, Rui Batista, Valdemar Máximo, Manuel Sobrinho-Simões |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.691979/full |
Similar Items
-
Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application
by: Sule Canberk, et al.
Published: (2021-05-01) -
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid
by: Machado José, et al.
Published: (2004-03-01) -
Oncocytic Change in Thyroid Pathology
by: Sylvia L. Asa, et al.
Published: (2021-05-01) -
Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms
by: David G. McFadden, et al.
Published: (2021-06-01) -
Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features
by: Shoko Kure, et al.
Published: (2021-12-01)